Trials / Terminated
TerminatedNCT03051711
Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions
An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Global Blood Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of GBT440 on oxygen saturation at rest and exercise, under hypoxic conditions, at Day 15 compared to Baseline.
Detailed description
This study in healthy subjects will evaluate GBT440 and its effects on cardio-pulmonary function under both normoxic and hypoxic conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GBT440 | Capsules which contain GBT440 drug substance in Swedish Orange |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-12-01
- Completion
- 2018-02-21
- First posted
- 2017-02-14
- Last updated
- 2019-10-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03051711. Inclusion in this directory is not an endorsement.